15/03/2016 | |
09:00 - 10:30 | PROFESSIONAL ORAL PRESENTATION |
09:00 - 10:30 | Assessment of the Eligible Use of New Oral Anticoagulants versus Acenocoumarol in a Sample of Lebanese Patients: A Retrospective Study |
09:00 - 10:30 | Adenosine receptor A3 selective Agonist protects against Doxorubicin induced Cardiotoxicity |
09:00 - 10:30 | Evaluation of Filler/Binder Properties of Modified Starches Derived from Plectranthus Esculentus by Direct Compress in Metronidazole TabletsFormulation |
09:00 - 10:30 | Prescribing Problems and Pharmacist Interventions in Community Practice. |
11:00 - 11:45 | Developments in Therapeutic Vaccines |
11:00 - 11:45 | Antibiotic Stewardship: A Local, National, and International Perspective |
11:45 - 12:30 | Building the “Hospital” of the Future – A Continuous Learning, Continuum of Care Model and the Opportunity for Health Professionals to Effect System Change |
11:45 - 12:30 | Means for Optimization of Drug Delivery |
12:30 - 13:15 | Clinical pharmacy today and the future |
12:30 - 13:15 | Nanomedicines for Cancer Therapy: Opportunities and Challenges |
13:15 - 15:00 | |
13:30 - 15:00 | PROFESSIONAL ORAL PRESENTATION |
13:30 - 15:00 | PROFESSIONAL ORAL PRESENTATION |
15:15 - 16:30 | PROFESSIONAL ORAL PRESENTATION |
16:45 - 18:00 | PROFESSIONAL ORAL PRESENTATION |
16:45 - 18:00 | PROFESSIONAL ORAL PRESENTATION |
16/03/2016 | |
04:45 - 18:00 | Evaluation of Adaptogenic and Related properties of G. Lucidum and P. Senega |
09:00 - 09:45 | Pharmacy Practice Applications of Epidemiology |
09:00 - 09:45 | Think globally, act locally - Update on Antimicrobial Resistance Surveillance in Abu Dhabi Emirate and the UAE |
09:00 - 10:00 | FDA Center of Excellence in Regulatory Science and Innovation: Innovations and Infrastructure in Global Drug Development, Progressive Regulations and Cooperative Partnerships |
09:45 - 10:30 | Major Challenges and Opportunities in Pharmaceutical Sector Governance |
09:45 - 10:30 | HAAD's Efforts to Rationalize the Use of Antibiotics in the Emirate of Abu Dhabi: A Success Story |
10:45 - 11:30 | Indicators for Pharmaceutical Care Services. What are they, Why we need them? |
10:45 - 11:30 | Advocacy issues with Parenteral nutrition |
11:30 - 12:15 | Creating a Healthy Aging Paradigm in the “Omics” Era |
11:30 - 12:15 | PK-based dose adjustment service when offered on a consultation basis: the case of antibiotics |
12:15 - 13:00 | Payment for Pharmacists' Medication Management Services - the Ontario Model |
12:15 - 13:00 | Pharmacist Role in the ICU |
13:15 - 14:00 | Non-prescription medicines: from regulation to dispensing |
13:15 - 14:00 | Bugs and Drug- No Easy Prescription |
14:00 - 14:45 | Development and practical use of decision analytic models in the medicinal provision system |
14:00 - 14:45 | Antimicrobial Resistance Crises : What should a Health Regulator Do About it? Thinking out of the Box |
15:00 - 16:30 | PROFESSIONAL ORAL PRESENTATION |
15:00 - 16:30 | PROFESSIONAL ORAL PRESENTATION |
17/03/2016 | |
09:00 - 10:00 | Community Pharmacists Expanded Role as Primary Care Providers - the Canadian Experience |
09:45 - 10:30 | Perspectives on Interprofessional Team-based Care to Address Chronic Diseases and Behavioral Health in Underserved Areas |
09:45 - 10:30 | Credential in Pharmacy Practice |
10:45 - 11:30 | Competencies in Safety Sciences for Medicines and Devices. |
10:45 - 11:30 | |
11:30 - 12:15 | Clinical Pharmacy – KPIs- Quantifying the practice’ |
11:30 - 12:15 | Mobile Smart Phone: Impact on Pharmacist's Role and Patient's Benefit |
12:15 - 13:00 | Unintended errors associated with health information technology |
12:15 - 13:00 | Role of the pharmacist in optimising medication use in pregnancy |
13:30 - 14:15 | Innovation in Pharmacy Education: Are you fit for the future |
14:15 - 15:00 | Academic leadership to reach knowledge goals |
Workshop schedule |
15/03/2016 | |||
13:30 - 15:00 | Conference Hall B | PROFESSIONAL ORAL PRESENTATION | |
15:15 - 16:30 | Conference Hall A | PROFESSIONAL ORAL PRESENTATION | |
13:30 - 15:00 | Conference Hall A | PROFESSIONAL ORAL PRESENTATION | |
16:45 - 18:00 | Conference Hall B | PROFESSIONAL ORAL PRESENTATION | |
17/03/2016 | |||
13:30 - 14:15 | Conference Hall B | Innovation in Pharmacy Education: Are you fit for the future Speaker: Prof. Luigi G. Martini, FRPharmS, MBA, Chair in Pharmaceutical Innovation & Chief Scientific Officer Start-Up Funding Club, Department of Pharmacy & Forensic Science, King's College London, UK | |
15/03/2016 | |||
16:45 - 18:00 | Conference Hall A | PROFESSIONAL ORAL PRESENTATION | |
17/03/2016 | |||
10:45 - 11:30 | Conference Hall A | Competencies in Safety Sciences for Medicines and Devices. Speaker: Dr. Hans H. Lindén, Leader European Projects & Global Affairs,, EUFEPS, Sweden | |
15/03/2016 | |||
11:45 - 12:30 | Conference Hall A | Building the “Hospital” of the Future – A Continuous Learning, Continuum of Care Model and the Opportunity for Health Professionals to Effect System Change Speaker: Prof. Robert Sindelar, PhD, VP Research & Academic Affairs, Providence Health Care, Assoc.Dean (Research), Faculty of Medicine, University of British Columbia, , Prof., Faculty of Pharmaceutical Sciences, Univ.of British Columbia, Canada | |
16/03/2016 | |||
16:45 - 18:15 | Conference Hall A | PROFESSIONAL ORAL POSTERS | |
16:45 - 18:15 | Conference Hall B | PROFESSIONAL ORAL POSTERS | |
17/03/2016 | |||
10:45 - 11:30 | Conference Hall B | Leadership in pharmacy Speaker: Prof. Joseph T. DiPiro PhD, Dean - VCU School of Pharmacy Archie O. McCalley Chair, , Virginia Commonwealth University School of Pharmacy, USA | |
16/03/2016 | |||
15:00 - 16:30 | Conference Hall A | PROFESSIONAL ORAL PRESENTATION | |
15/03/2016 | |||
09:00 - 10:30 | Conference Hall B | PROFESSIONAL ORAL PRESENTATION | |
11:45 - 12:30 | Conference Hall B | Means for Optimization of Drug Delivery Speaker: Prof. Abdulla Molokhia, PhD., VP, Research and Quality Affairs,, Pharco Corporation, Professor, Pharmaceutics, Egypt | |
16/03/2016 | |||
09:00 - 09:45 | Conference Hall A | Think globally, act locally - Update on Antimicrobial Resistance Surveillance in Abu Dhabi Emirate and the UAE Dr. Yousuf Naqvi, Officer Vaccines and Biologicals, Drugs and Medical Products, Regulation, , HAAD, UAE | |
09:45 - 10:30 | Conference Hall A | HAAD's Efforts to Rationalize the Use of Antibiotics in the Emirate of Abu Dhabi: A Success Story Dr. Hashem Tarifi, Department Manager, Drugs and Medical Products, Regulation, , HAAD, UAE | |
04:45 - 18:00 | Conference Hall A | Evaluation of Adaptogenic and Related properties of G. Lucidum and P. Senega | |
25/01/2017 | |||
09:00 - 12:00 | No location | Lecture 1 Speaker: Prof. Albert I. Wertheimer Prof., Ph.D., MBA, Director, Center for Pharmceutical Health Services Research &, Temple University, College of Pharmacy, Philadelphia, USA | |
09:00 - 12:00 | No location | Lecture 2 Speaker: Prof. AbdulLatif Al Ghaiheb Ph.D.,, Clinical Pharmacy Department, Chairman, School of Pharmacy, , King Saud University, Riyadh, Kingdom of Saudi Arabia | |
09:00 - 12:00 | No location | Lecture 3 | |
16/03/2016 | |||
09:00 - 13:00 | Workshop Room A | Workshop Schedule - 16th March | |
12:15 - 13:00 | Conference Hall B | Payment for Pharmacists' Medication Management Services - the Ontario Model Speaker: Dr. Alistair Bursey, Vice Chair of the Canadian Pharmacists Association (CPhA), Canada, Canada | |
17/03/2016 | |||
09:45 - 10:30 | Conference Hall A | Perspectives on Interprofessional Team-based Care to Address Chronic Diseases and Behavioral Health in Underserved Areas Speaker: Prof. Natalie D. Eddington, PhD, FAAPS, FCP, Dean and Professor, School of Pharmacy Executive Director, , University Regional Partnerships University of Maryland, USA | |
16/03/2016 | |||
15:00 - 16:30 | Conference Hall B | PROFESSIONAL ORAL PRESENTATION | |
17/03/2016 | |||
09:45 - 10:30 | Conference Hall B | Credential in Pharmacy Practice Speaker: Prof. Keith M Olsen, PharmD, FCCP, FCCM,, Professor and Chair, Department of Pharmacy Practice, , Nebraska Medical Center, Omaha, USA | |
16/03/2016 | |||
10:45 - 11:30 | Conference Hall A | Indicators for Pharmaceutical Care Services. What are they, Why we need them? Speaker: Dr. Ibrahim Al Khars, Ph.D.,, Managing Director/Business Development Manager and Senior Consultant,, People & Business Development Center, Dammam, KSA | |
15/03/2016 | |||
11:00 - 11:45 | Conference Hall B | Developments in Therapeutic Vaccines Speaker: Prof. Albert I. Wertheimer Prof., Ph.D., MBA, Director, Center for Pharmceutical Health Services Research &, Temple University, College of Pharmacy, Philadelphia, USA | |
11:00 - 11:45 | Conference Hall A | Antibiotic Stewardship: A Local, National, and International Perspective Speaker: Dr. Philip J. Schneider, Pharm.D., Officer ASHP Board, Director of Pharmacy, Olathe Medical Center, Kansas USA. USA | |
16/03/2016 | |||
11:30 - 12:15 | Conference Hall B | Creating a Healthy Aging Paradigm in the “Omics” Era Speaker: Prof. Robert Sindelar, PhD, VP Research & Academic Affairs, Providence Health Care, Assoc.Dean (Research), Faculty of Medicine, University of British Columbia, , Prof., Faculty of Pharmaceutical Sciences, Univ.of British Columbia, Canada | |
17/03/2016 | |||
12:15 - 13:00 | Conference Hall B | Role of the pharmacist in optimising medication use in pregnancy Speaker: Dr. Luke Grzeskowiak, Adjunct research fellow at the Robinson Research Institute, , University of Adelaide, South Australia, Australia | |
16/03/2016 | |||
09:00 - 09:45 | Conference Hall B | FDA Center of Excellence in Regulatory Science and Innovation: Innovations and Infrastructure in Global Drug Development, Progressive Regulations and Cooperative Partnerships Speaker: Prof. Natalie D. Eddington, PhD, FAAPS, FCP, Dean and Professor, School of Pharmacy Executive Director, , University Regional Partnerships University of Maryland, USA | |
13:15 - 14:00 | Conference Hall B | Non-prescription medicines: from regulation to dispensing Speaker: Dr. Mara Guerreiro, PharmD PhD PGDip, Deontologia e Legislação Farmacêutica, Senior Lecturer in Pharmacy Practice at ISCSEM (Instituto Superior de Ciências da Saúde Egas Moniz), , Portugal | |
17/03/2016 | |||
09:00 - 09:45 | Conference Hall B | Pharmacy Practice Applications of Epidemiology Speaker: Joaquima Serradell, PharmD,MPH, PhD, Temple University Hospital, Philadelphia, USA | |
15/03/2016 | |||
09:00 - 10:30 | Conference Hall B | Assessment of the Eligible Use of New Oral Anticoagulants versus Acenocoumarol in a Sample of Lebanese Patients: A Retrospective Study | |
12:30 - 13:15 | Conference Hall A | Clinical pharmacy today and the future Speaker: Prof. Joseph T. DiPiro PhD, Dean - VCU School of Pharmacy Archie O. McCalley Chair, , Virginia Commonwealth University School of Pharmacy, USA | |
17/03/2016 | |||
11:30 - 12:15 | Conference Hall B | Mobile Smart Phone: Impact on Pharmacist's Role and Patient's Benefit Speaker: Prof. AbdulLatif Al Ghaiheb Ph.D.,, Clinical Pharmacy Department, Chairman, School of Pharmacy, , King Saud University, Riyadh, Kingdom of Saudi Arabia | |
09:00 - 09:45 | Conference Hall A | Community Pharmacists Expanded Role as Primary Care Providers - the Canadian Experience Speaker: Dr. Alistair Bursey, Vice Chair of the Canadian Pharmacists Association (CPhA), Canada, Canada | |
09:00 - 13:00 | Workshop Room A | Workshop Schedule - 17th March | |
15/03/2016 | |||
09:00 - 18:00 | Professional Oral Presentation | Professional Oral Presentation -15th March | |
16/03/2016 | |||
03:00 - 18:15 | Professional Oral Presentation | Professional Oral Presentation -16 March | |
13:15 - 14:00 | Conference Hall A | Bugs and Drug- No Easy Prescription Dr. Rayhan Hashmey, Consultant Infectious Disease, Deputy Medical Director, Tawam Hospital | |
17/03/2016 | |||
11:30 - 12:15 | Conference Hall A | Clinical Pharmacy – KPIs- Quantifying the practice’ Speaker: Dr. Sherif Kamal, MSc,, Director Department of Pharmaceutical Services , Children cancer hospital Egypt Founder - Egyptian Association of Clinical Pharmacists, Egypt | |
16/03/2016 | |||
14:00 - 14:45 | Conference Hall A | Antimicrobial Resistance Crises : What should a Health Regulator Do About it? Thinking out of the Box Speaker: Dr. Hashem Tarifi, Department Manager, Drugs and Medical Products, Regulation, , HAAD, UAE | |
11:30 - 12:15 | Conference Hall A | PK-based dose adjustment service when offered on a consultation basis: the case of antibiotics Speaker: Prof. Franck Saint-Marcoux, Department of Pharmacology and Toxicology Limoges, University Hospital France | |
15/03/2016 | |||
12:30 - 13:15 | Conference Hall B | Nanomedicines for Cancer Therapy: Opportunities and Challenges Speaker: Prof. Erem Bilensoy,, President of EUFEPS, Ankara, Turkey | |
16/03/2016 | |||
10:45 - 11:30 | Conference Hall B | Advocacy issues with Parenteral nutrition Prof. Jay M. Mirtallo, MS, RPh, BCNSP, FASHP, FASPEN,, Professor of Clinical Pharmacy Director, MS in Health System Pharmacy, , The Ohio State University College of Pharmacy, USA | |
14:00 - 14:45 | Conference Hall B | Development and practical use of decision analytic models in the medicinal provision system Speaker: Prof. Roza Ismailovna Yagudina, Ph.D.,, Board Chairman of Moscow Pharmaceutical Society (MPS), Moscow, Russia | |
17/03/2016 | |||
14:15 - 15:00 | Conference Hall B | Academic leadership to reach knowledge goals Speaker: Prof. Patricia Acuna-Johnson MSc, Professor, School of Chemistry and Pharmacy Faculty of Pharmacy, , University of Valparaiso, Chile | |
12:15 - 13:00 | Conference Hall A | Unintended errors associated with health information technology Speaker: Prof. Kyle E. Hultgren, PharmD,, Director, Clinical Assistant Professor of Pharmacy Practice, Center for Medication Safety Advancement, , Purdue University College of Pharmacy, USA | |
16/03/2016 | |||
12:15 - 13:00 | Conference Hall A | Pharmacist Role in the ICU Speaker: Prof. Keith M Olsen, PharmD, FCCP, FCCM,, Professor and Chair, Department of Pharmacy Practice, , Nebraska Medical Center, Omaha, USA | |
09:45 - 10:30 | Conference Hall B | Major Challenges and Opportunities in Pharmaceutical Sector Governance Speaker: Prof. Emad Elazazy, PhD, MBA, PharmD, Bsc, Visiting Professor of Pharmaceutical Practice and Governance, Chairman & CEO of VALUE Institution for Education & Experiential Learning., Scientific Board member at M.O.H. National Training Institute, Cairo, Egypt | |
15/03/2016 | |||
11:00 - 13:00 | Workshop Room A | Workshop Schedule - 15th March | |
09:00 - 10:30 | Conference Hall B | Adenosine receptor A3 selective Agonist protects against Doxorubicin induced Cardiotoxicity | |
09:00 - 10:30 | Conference Hall B | Evaluation of Filler/Binder Properties of Modified Starches Derived from Plectranthus Esculentus by Direct Compress in Metronidazole TabletsFormulation | |
09:00 - 10:30 | Conference Hall B | Prescribing Problems and Pharmacist Interventions in Community Practice. | |
15:15 - 16:30 | Conference Hall A | PROFESSIONAL ORAL PRESENTATION |